While in the clinic the type of formulation largely depends on the type of cancer [reviewed in (Sharifi-Rad et al., 2021)], a recent study indicates that nanoparticle albumin-bound paclitaxel readily accumulates in DRG, but is also cleared faster than Cremophor EL paclitaxel (such as used in this study) (Klein et al., 2021). The gene discussed is ALB; the disease is cancer.